Minimally invasive procedure

Arthrex Wins Both Gold and Silver Medals at 2024 Edison Awards

Retrieved on: 
금요일, 4월 19, 2024
Orthopedic surgery, MIS, Trauma, Invention, Extremities, Surgeon, Gold, Meniscus, Minimally invasive procedure, Patient, Edison Awards, Elective surgery, Thomas Edison, Marketing, Film industry

NAPLES, Fla., April 19, 2024 /PRNewswire/ -- Arthrex, a global leader in minimally invasive surgical technology, has once again taken home prestigious medals for product innovation at the 37th annual Edison Awards .

Key Points: 
  • NAPLES, Fla., April 19, 2024 /PRNewswire/ -- Arthrex, a global leader in minimally invasive surgical technology, has once again taken home prestigious medals for product innovation at the 37th annual Edison Awards .
  • The MIS FiberTak® Achilles SpeedBridge™ Repair Implant System with Knotless Rip-Stop won Gold in the Surgical Innovations category.
  • That same year, Arthrex also won three gold awards for OrthoPedia , the InternalBrace™ 2.0 ligament augmentation repair system and for Nano arthroscopy.
  • The 2024 Edison Awards were presented on Thursday, April 18 at the Luminary Hotel and the Caloosa Sound Convention Center in Fort Myers, Florida.

SurGenTec® Receives FDA Clearance for OsteoFlo® HydroPutty™, a Hydrophilic Synthetic Bone Graft

Retrieved on: 
목요일, 3월 7, 2024
Medical Supplies, Medical Devices, FDA, Health, Surgery, Neurology, Minimally invasive procedure, Spine, Multimedia, MD, Blood, Physician, Food, Bone marrow, Baptist Health, Patient

This innovative formulation turns to a putty and offers superior handling characteristics with a resorption profile optimized for bone growth.

Key Points: 
  • This innovative formulation turns to a putty and offers superior handling characteristics with a resorption profile optimized for bone growth.
  • Its unique hydrophilic bonds enable the attachment of growth factors and provide an ideal scaffolding for bone growth.
  • HydroPutty differentiates itself by allowing me to deliver next generation hydrophilic bone graft to maximize fusion in minimally invasive surgery."
  • OsteoFlo HydroPutty provides physicians with a fully synthetic bone graft option, minimizing the risks associated with human tissue.

A clearer vision for surgical robotics: CMR Surgical announces significant update to Versius

Retrieved on: 
목요일, 2월 8, 2024
Surgeon, CMR, ICG, General surgery, 3D, Bose, Patient, Indocyanine green, CMR Surgical, Minimally invasive procedure, GMT, Contraindication, Communication, Thought, Sale, CE, Health, Eye, Gloucestershire Royal Hospital, Anatomy, MAS, Fatigue

CMR Surgical (CMR) – the global surgical robotics business – has today announced the launch of vLimeLite – an integrated fluorescence imaging system to visualise ICG (Indocyanine green), which will give surgeons enhanced visualisation, where indicated.

Key Points: 
  • CMR Surgical (CMR) – the global surgical robotics business – has today announced the launch of vLimeLite – an integrated fluorescence imaging system to visualise ICG (Indocyanine green), which will give surgeons enhanced visualisation, where indicated.
  • Supratim Bose, Chief Executive Officer of CMR Surgical, commented: “With 3D HD visualisation, surgeons already have a fantastic view of their operating field at our Versius console.
  • As long-term partners of CMR, we were delighted to be the first to get our hands on its ICG system.
  • Through the Versius Connect app, Versius Trainer and CMR clinical registry, Versius unleashes a wealth of insights to ultimately improve surgical care.

A clearer vision for surgical robotics: CMR Surgical announces significant update to Versius

Retrieved on: 
목요일, 2월 8, 2024
Surgeon, CMR, ICG, General surgery, 3D, Bose, Patient, Indocyanine green, CMR Surgical, Minimally invasive procedure, GMT, Contraindication, Communication, Thought, Sale, CE, Health, Eye, Gloucestershire Royal Hospital, Anatomy, MAS, Fatigue

CMR Surgical (CMR) – the global surgical robotics business – has today announced the launch of vLimeLite – an integrated fluorescence imaging system to visualise ICG (Indocyanine green), which will give surgeons enhanced visualisation, where indicated.

Key Points: 
  • CMR Surgical (CMR) – the global surgical robotics business – has today announced the launch of vLimeLite – an integrated fluorescence imaging system to visualise ICG (Indocyanine green), which will give surgeons enhanced visualisation, where indicated.
  • Supratim Bose, Chief Executive Officer of CMR Surgical, commented: “With 3D HD visualisation, surgeons already have a fantastic view of their operating field at our Versius console.
  • As long-term partners of CMR, we were delighted to be the first to get our hands on its ICG system.
  • Through the Versius Connect app, Versius Trainer and CMR clinical registry, Versius unleashes a wealth of insights to ultimately improve surgical care.

Mindray Showcased Latest Innovations in Smart Hospital Solutions at Arab Health 2024

Retrieved on: 
월요일, 1월 29, 2024
Medical imaging, Orthopedic surgery, ICU, Hospital, Minimally invasive procedure, Workflow, Medicine, TV80, Transport, ERAS, Medical device

DUBAI, UAE, Jan. 29, 2024 /PRNewswire/ -- Mindray ("the company"), a leading global provider of medical devices and solutions, is attending one of the largest exhibitions in the medical field, the Arab Health 2024 from Jan. 29 to Feb. 1.

Key Points: 
  • DUBAI, UAE, Jan. 29, 2024 /PRNewswire/ -- Mindray ("the company"), a leading global provider of medical devices and solutions, is attending one of the largest exhibitions in the medical field, the Arab Health 2024 from Jan. 29 to Feb. 1.
  • This year, under the theme of "Exploring the Future of Smart Healthcare", Mindray showcased its latest innovations in Smart Hospital Solutions at its booth.
  • Expo visitors can witness Mindray's comprehensive product portfolio from ER, OR, ICU, ERAS, and Medical Imaging solutions to Orthopedics solutions at booth S1.
  • Following Arab Health 2024, Mindray will also participate at Medlab Middle East on Feb. 5-8, where it will be presenting its advanced total solutions in In-Vitro Diagnostics.

VANTEDGE MEDICAL APPOINTS BRIGHAM BRANDON AS CHIEF OPERATIONS OFFICER

Retrieved on: 
금요일, 1월 12, 2024
Patient, Minimally invasive procedure, OEM, Trust, SAN, Wake Forest University, Medical device, Medtech, KPI, Medtronic, Plant, TMK, News, 3D printing

SAN JOSE, Calif., Jan. 12, 2024 /PRNewswire/ -- Vantedge Medical ("Vantedge"), proven partner to medical device OEM customers in complex precision machining, sophisticated sheet metal manufacturing and assembly and portfolio company of Aterian Investment Partners ("Aterian"), has appointed Brigham Brandon as Chief Operations Officer ("COO").

Key Points: 
  • SAN JOSE, Calif., Jan. 12, 2024 /PRNewswire/ -- Vantedge Medical ("Vantedge"), proven partner to medical device OEM customers in complex precision machining, sophisticated sheet metal manufacturing and assembly and portfolio company of Aterian Investment Partners ("Aterian"), has appointed Brigham Brandon as Chief Operations Officer ("COO").
  • Brigham Brandon brings more than 20 years of experience in operations and supply chain to Vantedge as COO.
  • Most recently at Viant Medical, he led operations for the Advanced Metals Solutions business, which included 7 factories and over 1500 full-time employees.
  • Brigham holds a BA in Philosophy from Wake Forest University and served as an Officer in the U.S. Army.

World-Renowned Surgeon Joins NYU Langone Health as Division Director of Minimally Invasive and Specialty Gynecologic Surgery

Retrieved on: 
수요일, 1월 3, 2024
Hospital, Division, NYU Langone Health, Research, Minimally invasive procedure, NYU, University, Endometriosis, Patient, Reproductive Sciences, Gynaecology, Nursing

NEW YORK, Jan. 3, 2024 /PRNewswire/ -- A leading gynecologic surgeon, Ted T. Lee, MD , has joined NYU Langone Health as director of the Division of Minimally Invasive and Specialty Gynecologic Surgery and chief of surgical innovation for gynecology in NYU Grossman School of Medicine's Department of Obstetrics and Gynecology , effective January 1.

Key Points: 
  • NEW YORK, Jan. 3, 2024 /PRNewswire/ -- A leading gynecologic surgeon, Ted T. Lee, MD , has joined NYU Langone Health as director of the Division of Minimally Invasive and Specialty Gynecologic Surgery and chief of surgical innovation for gynecology in NYU Grossman School of Medicine's Department of Obstetrics and Gynecology , effective January 1.
  • In his new roles, Dr. Lee will oversee minimally invasive surgical services that treat common and complex gynecologic conditions at NYU Langone's Manhattan campus and NYU Langone Hospital—Brooklyn.
  • "I am dedicated to advancing the boundaries of minimally invasive gynecologic surgery, ensuring world-class, patient-centered care," said Dr. Lee.
  • "This is an exciting chapter and I look forward to contributing to the continued excellence in women's health care at NYU Langone."

Karmanos Cancer Institute receives 2024 Women's Choice Awards® for cancer care and patient experience

Retrieved on: 
수요일, 12월 20, 2023
National Comprehensive Cancer Network, Choice, Travel, Agency, Karmanos Cancer Institute, Health care, Woman, Breast cancer, Disease, Minimally invasive procedure, Accreditation, Hospital, Nursing, Morale, American College, Patient, Surgeon, ACS, Communication

DETROIT, Dec. 20, 2023 /PRNewswire/ -- The Barbara Ann Karmanos Cancer Institute has been named one of America's 2024 Best Hospitals for Cancer Care and one of the country's 100 Best Hospitals for Patient Experience by the Women's Choice Award®, America's trusted referral source for the best in health care. This is the 11th consecutive year Karmanos has been recognized by the Women's Choice Award® since the inception of the national list.

Key Points: 
  • DETROIT, Dec. 20, 2023 /PRNewswire/ -- The Barbara Ann Karmanos Cancer Institute has been named one of America's 2024 Best Hospitals for Cancer Care and one of the country's 100 Best Hospitals for Patient Experience by the Women's Choice Award® , America's trusted referral source for the best in health care.
  • "Every single staff member at Karmanos is dedicated to providing the best cancer care and experience for every patient, and this designation shows we're on the right track."
  • Delia Passi, founder and CEO of the Women's Choice Award® and a breast cancer survivor, emphasized that Karmanos and all 2024 Best Hospitals for Cancer Care deliver the most important care to women.
  • The Women's Choice Award® recognizes the Barbara Ann Karmanos Cancer Institute as one of the 100 Best Hospitals for Patient Experience in the U.S.

Global Urology Surgical Instruments Market Expected to Surge at 8% CAGR: Rising Urological Disorders and Advancements Drive Growth - ResearchAndMarkets.com

Retrieved on: 
금요일, 11월 10, 2023
Surgery, Health, Medical Supplies, Urology, Research, Prevalence, Patient satisfaction, Investment, Minimally invasive procedure, Stryker Corporation, Olympus Corporation, System, Urinary incontinence, Compound annual growth rate, KARL, Ageing, Instrument, Kidney, Growth, Endoscopy, Chronic kidney disease, Patient, Video game, Medical device

The global urology surgical instruments market is poised for significant growth, with a projected Compound Annual Growth Rate (CAGR) of 8% during the forecast period from 2023 to 2031.

Key Points: 
  • The global urology surgical instruments market is poised for significant growth, with a projected Compound Annual Growth Rate (CAGR) of 8% during the forecast period from 2023 to 2031.
  • Urology surgical instruments are crucial in diagnosing and treating urological conditions, and several factors are driving the market's expansion.
  • Rising Prevalence of Urological Disorders: Increasing cases of urological disorders, including kidney stones, urinary incontinence, and prostate disorders, are driving the demand for urology surgical procedures and instruments.
  • Technological Advancements and Innovations: Continuous advancements in urology surgical instruments, including robotic-assisted systems and imaging technologies, are enhancing precision and reducing invasiveness in urological surgeries.

BioWave® Named TOP Pain Management Device Provider 2023

Retrieved on: 
수요일, 11월 8, 2023
Patient, FDA, Trial of the century, Chronic pain, Allergy, Silver, Morphine, Skin, Rehabilitation, Pain management, Sleep, Minimally invasive procedure, Brain, Skiing, Motion, Dentistry, Poultry farming, Medical imaging, Pain, Therapy

NORWALK, Conn., Nov. 8, 2023 /PRNewswire/ -- BioWave®, a pioneer in pain management technology, has been recognized as the TOP Pain Management Device Provider of 2023 by MedTech Outlook.

Key Points: 
  • NORWALK, Conn., Nov. 8, 2023 /PRNewswire/ -- BioWave®, a pioneer in pain management technology, has been recognized as the TOP Pain Management Device Provider of 2023 by MedTech Outlook.
  • In a recent article titled "BioWave® Revolutionizing Pain Management with Smarter Pain-Blocking Technology®," MedTech Outlook highlighted the groundbreaking work of BioWave in the field of pain relief.
  • He already had an early prototype of his BioWave smarter pain-blocking medical device at home and used it to treat his post-operative pain.
  • © 2021 World Institute of Pain, Pain Practice, June 2021; 21(5):578-587
    Reduced Pain and Improved Function Following Short-Term Use of Noninvasive BioWave High-Frequency Peripheral Nerve Stimulation for Pain Management.